[go: up one dir, main page]

NO20081909L - Bovint viralt diare virus (BVDV), samt BVDV-vaksine - Google Patents

Bovint viralt diare virus (BVDV), samt BVDV-vaksine

Info

Publication number
NO20081909L
NO20081909L NO20081909A NO20081909A NO20081909L NO 20081909 L NO20081909 L NO 20081909L NO 20081909 A NO20081909 A NO 20081909A NO 20081909 A NO20081909 A NO 20081909A NO 20081909 L NO20081909 L NO 20081909L
Authority
NO
Norway
Prior art keywords
bvdv
diarrhea virus
bovine viral
viral diarrhea
well
Prior art date
Application number
NO20081909A
Other languages
English (en)
Inventor
Xuemei Cao
Chichi Huang
Michael George Sheppard
Gabriele Zybarth
Original Assignee
Zoetis P Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis P Llc filed Critical Zoetis P Llc
Publication of NO20081909L publication Critical patent/NO20081909L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/18—Togaviridae; Flaviviridae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Det beskrives et bovint viralt diarévirus omfattende i det minste en helikasedomene aminosyremutasjon hvor mutasjonen i NS3 domene resulterer i tap av gjenkjenning av et monoklonalt antistoff rettet mot villtype NS3, men hvor viral RNA-replikasjon og generering av infeksiøse virus opprettholdes. Foreliggende oppfinnelse er nyttig for eksempel for å produsere en merket bovin viral diaré virusvaksine, eller for å differensiere mellom vaksinerte og infiserte eller ikke-vaksinerte dyr.
NO20081909A 2005-12-07 2008-04-21 Bovint viralt diare virus (BVDV), samt BVDV-vaksine NO20081909L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74831205P 2005-12-07 2005-12-07
PCT/IB2006/003412 WO2007066188A2 (en) 2005-12-07 2006-11-24 Marked bovine viral diarrhea virus vaccines

Publications (1)

Publication Number Publication Date
NO20081909L true NO20081909L (no) 2008-05-21

Family

ID=38123251

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081909A NO20081909L (no) 2005-12-07 2008-04-21 Bovint viralt diare virus (BVDV), samt BVDV-vaksine

Country Status (16)

Country Link
US (2) US20080305130A1 (no)
EP (1) EP1973565B1 (no)
JP (1) JP2009519014A (no)
KR (2) KR101097547B1 (no)
CN (1) CN101355963B (no)
AR (1) AR057225A1 (no)
AU (1) AU2006323028B2 (no)
BR (1) BRPI0619566A2 (no)
CA (1) CA2639074C (no)
NO (1) NO20081909L (no)
NZ (1) NZ567668A (no)
RU (1) RU2394594C2 (no)
TW (1) TW200734463A (no)
UA (1) UA95619C2 (no)
WO (1) WO2007066188A2 (no)
ZA (1) ZA200803558B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2130912A1 (en) * 2008-06-04 2009-12-09 Institut für Viruskrankeiten und Immunprophylaxe Pestivirus replicons providing an RNA-based viral vector system
CN102517260A (zh) * 2011-12-29 2012-06-27 中国人民解放军军事医学科学院野战输血研究所 携带牛病毒性腹泻病毒非结构蛋白ns3优势区的融合蛋白及其重组表达方法与应用
WO2014033149A1 (en) * 2012-08-29 2014-03-06 Intervet International B.V. Marker vaccine
US9480739B2 (en) * 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
CN103197082B (zh) * 2013-04-16 2015-07-15 深圳出入境检验检疫局动植物检验检疫技术中心 牛病毒性腹泻病毒抗体快速检测试纸条
EA025263B1 (ru) * 2014-06-23 2016-12-30 Общество С Ограниченной Ответственностью "Научно-Производственный Центр Пробиотех" Разбавитель-адъювант для сухой живой вакцины против трихофитии крупного рогатого скота
CN110554187B (zh) * 2018-05-30 2022-07-05 内蒙古元山生物科技有限公司 一种用于检测牛病毒性腹泻病毒抗体的表达蛋白、elisa试剂盒及其制备方法和应用
KR102434714B1 (ko) * 2021-02-16 2022-08-23 바디텍메드(주) 중화 항체 및 인터페론-감마 생성 여부를 이용한 능동 면역 진단을 위한 정보 제공 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593873A (en) 1986-01-27 1997-01-14 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5709865A (en) 1994-11-10 1998-01-20 Biostar Inc. Immunogenic composition against Bovine Viral Diarrhea Virus II glycoprotein 53 (BVDV-II gp53)
US6001613A (en) * 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
US6060457A (en) 1996-06-20 2000-05-09 Universite De Montreal DNA plasmid vaccine for immunization of animals against BVDV
US6168942B1 (en) * 1998-11-10 2001-01-02 Pfizer Inc. Attenuated forms of bovine viral diarrhea virus
JP4864661B2 (ja) * 2006-11-22 2012-02-01 東京エレクトロン株式会社 太陽電池の製造方法及び太陽電池の製造装置
EP3518608A4 (en) 2016-09-30 2019-08-21 Guangdong Oppo Mobile Telecommunications Corp., Ltd. SIGNAL TRANSMISSION PROCESS AND DEVICE

Also Published As

Publication number Publication date
CN101355963B (zh) 2012-03-21
EP1973565A2 (en) 2008-10-01
RU2394594C2 (ru) 2010-07-20
US20120021001A1 (en) 2012-01-26
UA95619C2 (ru) 2011-08-25
KR101097547B1 (ko) 2011-12-22
JP2009519014A (ja) 2009-05-14
AU2006323028A1 (en) 2007-06-14
ZA200803558B (en) 2009-09-30
CA2639074C (en) 2013-10-08
WO2007066188A2 (en) 2007-06-14
RU2008120331A (ru) 2010-01-20
BRPI0619566A2 (pt) 2011-10-04
KR20110045072A (ko) 2011-05-03
CN101355963A (zh) 2009-01-28
NZ567668A (en) 2011-07-29
US20080305130A1 (en) 2008-12-11
KR101045165B1 (ko) 2011-06-30
WO2007066188A3 (en) 2008-06-05
KR20080065696A (ko) 2008-07-14
TW200734463A (en) 2007-09-16
CA2639074A1 (en) 2007-06-14
HK1121698A1 (en) 2009-04-30
AR057225A1 (es) 2007-11-21
AU2006323028B2 (en) 2010-02-25
EP1973565B1 (en) 2013-05-15

Similar Documents

Publication Publication Date Title
NO20081909L (no) Bovint viralt diare virus (BVDV), samt BVDV-vaksine
TW200512457A (en) Method of diagnosing SARS corona virus infection
DK1292328T3 (da) Kimære humant papillomvirus- (HPV) - molekyler og deres anvendelse
NO20072253L (no) Forbedrede vaksiner
ATE528016T1 (de) Virusähnliche partikel als paramyxovirus- impfstoffe
MY147379A (en) Chimeric viruses presenting non-native surface proteins and uses thereof
MX2021012695A (es) Vacuna de subunidad del virus de la fiebre porcina clasica (csfv).
NO20050396L (no) Adjuvant viral partikkel
WO2004016586A3 (en) Compositions and methods related to flavivirus envelope protein domain iii antigens
MY163972A (en) Attenuated recombinant newcastle disease virus and vaccine containing the same
CY1106310T1 (el) Καθορισμος hbv αντιγονων για χρηση σε εμβολια
Gasmi et al. A global survey in the developmental landscape of possible vaccination strategies for COVID-19
DK1425404T3 (da) Vaccinia-MVA-E3L-mutanter og anvendelse deraf
DE69936337D1 (de) Verfahren zur entwicklung von einem hiv impfstoff
ES2421543T3 (es) Método para la preparación de virus y proteínas del PRRS, y kits de pruebas de diagnóstico para su detección
BR9905352A (pt) Formas atenuadas do vìrus da diarréia bovina
ATE456958T1 (de) Mannose als adjuvant für intranasale vakzine
Harmsen et al. Effect of thiomersal on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles as assessed by novel ELISAs specific for either 146S or 12S particles
AR067439A1 (es) Virus quimericos antigenicos de virus de encefalitis de st. louis/virus dengue tipo 4
ATE267256T1 (de) Hepatis e-virus antigene und dessen verwendungen
AR047581A1 (es) Vacunas de calicivirus felino
SG135990A1 (en) Competitive enzyme linked immunosorbent assay (c-elisa) for the detection of a flavivirus specific antibody
CL2010001175A1 (es) Composicion de vacuna que comprende un antigeno de proteina viral 2 (vp-2) del virus causante de la enfermedad de la bursitis infecciosa (ibdv).
ATE494377T1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
WO2007002587A3 (en) Inhibitors of epstein barr virus nuclear antigen 1

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ZOETIS P LLC, US

FC2A Withdrawal, rejection or dismissal of laid open patent application